Non–small cell lung carcinomaPatient-reported outcomePsychometric propertiesSymptom assessmentIntroduction:The NSCLC Symptom Assessment Questionnaire (NSCLC-SAQ) was developed to assess NSCLC symptom severity in accordance with Food and Drug Administration evidentiary expectations leading to Food and Drug ...
摘要: Purpose: The purpose of this article was to describe the process and results of the preliminary qualitative development of a new symptoms-based patient reported outcome (PRO) measure intended for assessing treatment benefit in clinical trials of advanced non small cell lung cancer (NSCLC)....
This study proposed clinically MWPC thresholds, and group-level minimal important change/difference (MIC/MID) thresholds for both improvement and worsening for the Non-Small Cell Lung Cancer- Symptom Assessment Questionnaire (NSCLC-SAQ) total and symptom scores.#Blinded patient data (N=246) from ...
McCarrier KP, Atkinson TM, Debusk KPA, Liepa AM, Scanlon M, Coons SJ. Qualitative development and content validity of the Non-small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ), A Patient-reported Outcome Instrument. Clin Ther. 2016;38(4):794‐810....
Qualitative development and content validity of the Non-small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ), A Patient-reported Outcome Instrument. Clin Ther. 2016;38(4):794‐810.Development of a Patient-Reported Outcome Instrument to Evaluate Symptoms of Advanced NSCLC: ...
(MWPC) thresholds of 2 patient-reported outcome (PRO) measures in NSCLC: the Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function (PF) short form (SF) 8c and the Non-Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ).#Data came from 2 Phase 3 ...